ABSTRACT This report describes the design and synthesis of gold nanostars (AuNSs) containing liposomes by the in situ reduction of gold precursor, HAuCl4 (pre-encapsulated within the liposomes) through HEPES diffusion and reduction. Compared with the conventional process that encapsulates the pre-synthesized gold nanoparticles into liposomes during the thin-film hydration step, this facile and convenient method allows the formation and simultaneous encapsulation of AuNSs within liposomes. The absorption spectra of AuNSs can be tuned between visible and near infra-red (NIR) regions by controlling the size and morphology of AuNSs through varying the concentrations of HAuCl4 and HEPES. As a proof of concept, we demonstrate the synthesis of AuNSs with a maximum absorbance at 803 nm within the temperature-sensitive liposomes. These liposomes can produce stronger photoacoustic signals (1.5 fold) in the NIR region than blood. Furthermore, when there are drugs (i.e., doxorubicin) within these liposomes, the irradiation with the NIR pulse laser will disrupt the liposomes and trigger the 100% release of these pre-encapsulated drugs within 10 seconds. In comparison, there is neglectable contrast enhancement or minor release (10%) of drugs for the pure liposomes under the same conditions. Finally, cell experiment shows the potential therapeutic application of this system.
INTRODUCTION
Light sensitive liposomes have attracted increasing attention due to their ability to induce controlled drug release in terms of time, location, and dosage [1, 2] . The most convenient and straightforward way to synthesize such liposomes is to incorporate photosensitizing components within the liposomes. They can be lipid-like chemicals that undergo conformational change under laser irradiation or nanoparticles that absorb light and convert the photon energy into thermal energy [3, 4] . Gold nanoparticles are one of the most attractive photosensitizing agents due to their biocompatibility and distinctive optical properties. For example, liposomes containing gold nanoparticles can be triggered with a 532 nm pulse laser to release the encapsulated fluorescent dyes and gold nanorods with a characteristic surface plasmon band at 792 nm (longitudinal) can be incorporated into lipid layers to provide a theranostic platform for siRNA delivery to the tumour [5] [6] [7] . Currently, the integration of gold nanoparticles and liposomes is mainly achieved through hydrating the lipid film with the aqueous solution containing pre-synthesized nanoparticles. This procedure is simple and convenient, but it usually suffers from the low encapsulation of nanoparticles [8] .
This article reports a protocol for the in-situ synthesis of gold nanoparticles within liposome vehicles as an alternative strategy (Scheme 1). Specifically, it starts with the formulation of chloroauric acid (HAuCl4) containing liposomes before reducing the encapsulated HAuCl4 to gold nanoparticles using a mild reducing agent (i.e., 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid (HEPES)) [9, 10] . As a proof-of-concept, gold nanostars (AuNSs) Scheme 1 Schematic of the synthesis of AuNS-liposome complex by diffusion controlled method and its use in light-controlled drug release.
with the maximum absorbance in the near-infrared (NIR) wavelength range (i.e., 803 nm) were synthesized within the temperature-sensitive liposomes. These AuNSs containing liposomes showed stronger photoacoustic signals (1.5 fold) in the NIR region than fresh blood. Furthermore, when there were drugs (i.e., doxorubicin (Dox)) within these liposomes, the irradiation with the NIR pulse laser would disrupt the liposomes and trigger the 100% release of preencapsulated Dox within 10 seconds. In contrast, there was negletable contrast enhancement and minor laser-triggered release (10%) for the liposomes without AuNSs. Finally, cancer cells were treated with these Dox-containing AuNS-liposomes with or without the laser stimulation. The cell viability assay showed that over 90% cells died only under the NIR laser treatment. Taking together, this article reported a convenient and efficient way to prepare the AuNS-liposome complex for both photoacoustic imaging and controlled drug delivery.
MATERIALS AND METHODS
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1-palmitoyl-2-hydroxy-sn-glycero-3 phospho-choline (MPPC) and 1, 2-distearoyl-sn-glycero-3-phosphoethanol-amine-N-[carboxy (polyethylene glycol)-2000] (ammonium salt) (DSPE-PEG2000) were purchased from Avanti Polar Lipids (Alabama, US). HAuCl4 was purchased from ACROS Organics. Fresh mouse blood was collected from animal facility center, Nanyang Technological University. All other chemicals unless otherwise mentioned were purchased from Sigma-Aldrich. Deionized (DI) water was purified by a Millipore Milli-DI water purification system.
Synthesis of liposomes encapsulating HAuCl4 or HAuCl4/Dox
Liposomes encapsulating HAuCl4 were synthesized by thin film hydration method [11, 12] . Briefly, the constituent phospholipids (DPPC, MPPC and DSPE-PEG2000) were mixed and dissolved in chloroform in a molar ratio of 86:10:4 (15.9 mg : 1.3 mg : 2.8 mg). The mixture was evaporated in a rotary evaporator to form a thin lipid layer, which was then re-hydrated by solution containing HAuCl4 (20 mmol L −1 ) for AuNS-liposome complex. Then the synthesized liposomes were extruded using a hand-held mini-extruder. Liposomes were purified from unencapsulated HAuCl4 by centrifuging the liposomes at 10,000 ×g at 4°C for 60 min. To prepare liposomes containing HAuCl4/Dox, 2 mg of Dox and 1 µL of triethylamine (TEA) were added to the chloroform along with the lipids as above [13] . The rest procedure was the same as the above.
Diffusion controlled reduction of HAuCl4 in liposomes with HEPES
After the removal of unencapsulated HAuCl4, the liposomes were reconstituted with 5 mL solution containing 1 mol L −1 HEPES. The mixture was left in dark for one hour to allow the reduction of HAuCl4 by HEPES [14] . Then the liposomes were purified by gel filtration chromatography using PD-10 desalting column (GE Healthcare) to remove the excess HEPES. Purified samples were then stored at 4°C until further use.
Characterization
Hydrodynamic diameter and zeta potential of the prepared liposomes were measured with dynamic light scattering (DLS, ZetaPALS analyser, BIC). Each sample was measured at least 6 times. The UV-vis absorbance was measured with UV-visible spectrophotometer (UV-2450, Shimadzu).
For transmission electron microscopy (TEM), 10 µL of sample solution was placed on 200 mesh formvar carbon coated copper grids (FCF-200-Cu, Electron Microscopy Sciences) and air-dried. The sample was then negatively stained using 3% uranyl acetate for 1.5 min followed by washing with DI water. Finally, the grid samples was air-dried overnight before imaging with FEI Tecnai G2 Spirit Bio-TWIN electron microscope, operated at 120 kV.
For high resolution TEM (HRTEM) imaging, the liposomes were lysed with Triton X-100 and AuNSs were collected after centrifuging the samples at 10,000 ×g for 15 min at 4°C. AuNSs were then re-suspended in DI water and 5 µL of this suspension was placed on 200 mesh formvar carbon coated copper grids (FCF-200-Cu, Electron Microscopy Sciences). The grids were completely dried in a dry cabinet and were imaged using TEM (FEI G2 spirit, 120 kV, America).
The concentration of AuNSs in the liposomal solution was determined using inductively coupled plasma spectrometer (ICP, Prodigy ICP Spectrometer). Briefly, 100 µL AuNS-liposome complex or Dox-AuNS-liposome complex solutions after purification were digested using 250 µL aqua-regia overnight. The digested samples were then diluted to 10 mL using DI water and the gold content was measured by ICP Spectrometer. Gold standard solution was used to construct the standard curve.
Photoacoustic measurement
The setup for the photoacoustic system is depicted in Supplementary information (Fig. S1 ). Pulsed laser diode (QD-Q1910-SA-TEC, Quantel, France) operated at 803 nm was the light source with a pulse width of~136 ns and a pulse energy of 1.4 mJ at 7 kHz repetition rate. A ground glass was used in front of the laser window to make the laser beam more uniform. The sample was placed inside a water bath. The liposome solution and/or tissue sample was irradiated with the homogeneous laser beam and the photoacoustic signals were collected by the ultrasound transducer. A single element ultrasound transducer (V323-SU/2.25 MHz, Olympus NDT) with 2.25 MHz central frequency, 13 mm active area, and 70% nominal bandwidth was used for all the photoacoustic experiments. The photoacoustic signals were subsequently amplified, and band pass was filtered by an Amplifier/Filter (A/F) unit (Olympus-NDT, 5072PR). Finally, the output from A/F unit was digitized with a data acquisition card (GaGe, compuscope 4227) and stored in the computer. For photoacoustic spectrum measurement, an optical parametric oscillator (Continuum, Surelite OPO) system pumped by a 532 nm Nd:YAG laser (Continuum, Surelite Ex) was used. The laser wavelength was varied from 660 to 900 nm to obtain the photoacoustic spectrum.
Laser triggered Dox release from Dox-AuNS-liposome complex 50 µL of Dox-AuNS-liposome complex was placed on a microscopic slide, two centimetres away from the laser window. The sample was irradiated with the pulsed laser at 803 nm for varying time points (0-10 s) with 5 mm laser spot and the output energy of 1.4 mJ cm −2 . The solution could be collected after each cycle and was replaced with fresh aliquots. The collected samples were diluted in DI water and were centrifuged at 10,000 ×g to remove the DoxAuNS-liposome complex. The supernatant containing released Dox was quantified by measuring the absorbance of Dox at 480 nm using a UV-vis spectrophotometer (Spectramax). The same protocol was carried for the Dox-liposome complex without AuNSs. For in vitro drug release experiments, B16 F10 melanoma cells (ATCC) were seeded on a 48-well plate overnight before being incubated with Dulbecco's Modified Eagle medium (DMEM) containing 10% FBS and the liposome samples. Free Dox and AuNSs acted as controls. After 24 h of labelling, the liposome-containing medium was replaced with fresh one. The cells were immediately treated with 803 nm pulse laser for 120 s with the energy of 1.4 mJ cm −2 . Subsequently, the viability of cells was quantified using Alamar Blue and the results were expressed as the percentage of viable cells as against the untreated cells. Alongside, live/dead staining was performed using calcein acetomethoxy (CAM) and propidium iodide (PI) for qualitative analysis of the effect of laser treatment. Upon exposure to laser, the cells were labelled with CAM (2 μmol L −1 ) and PI (4 μmol L −1 ) in DMEM without phenol red solution. Following 30 min incubation, the cells were washed and rinsed with phosphate-buffered saline before being placed in DMEM without phenol red. The cells were then imaged using LX71 inverted fluorescence microscope (Olympus) equipped with a Retiga-2000R CCD camera. The images were captured at 20× image magnification with an exposure time of 50 ms and a gain number of 7. Finally, the images were processed to normalize the background colour using ImageJ software.
RESULTS

Synthesis and characterization of AuNS-liposome complex
HAuCl4 containing liposomes were prepared by hydrating the lipid film with 20 mmol L −1 HAuCl4 aqueous solution (Scheme 1). After removing the free HAuCl4, the liposomes were reconstituted with 1 mol L −1 HEPES solution for one hour in the dark. Later, the HEPES buffer was replaced with DI water by using gel filtration chromatography. The as-synthesized liposomes had a zeta potential of −35.33±1.53 mV. The as-synthesized liposomes had a hydrodynamic diameter of 422.6±0.9 nm (Fig. S2a) . However, the size increased during the subsequent storage, especially after 14 days (Fig. S2b) . Thus all the experiments in this report were done with freshly prepared liposomes within 3 days. Their maximum UV-vis absorbance is at 803 nm (Fig. 1a) , which falls within the 'optical window' in biological tissues [15, 16] . When the liposomes were examined under TEM, AuNSs are seen on the lipid memebrane of liposomes (Fig. 1b) . After being extracted from the liposomes and examined under HRTEM, these AuNSs with branches have the similar irregular shape with the diameter of approximately 44 nm (Fig. 1c) .
AuNS-liposome complex as contrast agents for photoacoustic imaging
The photoacoustic spectrum of AuNS-liposome complex was collected as the laser was continuously tuned from 660 to 900 nm in a 10 nm increment. As shown in Fig. 2a , the complex shows the strongest photoacoustic contrast between 750 and 870 nm. It is noted that this laser scanning did not change the absorption of AuNS-liposomes. Taking 803 nm as the preferred wavelength, we further studied the relation between the liposome concentration and photoacoustic signal. As shown in Fig. 2b , there is a linear relationship between the photoacoustic signal strength and the concentration of liposomes.
The photoacoustic signals were further recorded from both liposome samples and fresh blood (from mice). Blood being an intrinsic absorber of light produces photoacoustic signals and therefore, any potential contrast agent is usually compared against the blood for their potency [17] [18] [19] . Since the PA signal of AuNS-liposomes was related with their concentration, a series of PA signal was collected (Table S1 and Fig. 2b ). Clearly, 2 mg mL −1 was the minimal concentration for the identification of AuNS-liposomes from the blood. Fig. 2c shows the direct photoacoustic signal comparison between the liposomes (2 mg mL −1 ) and blood. The peak-to-peak photoacoustic signal from AuNS-liposome complex was 675.9 mV while that of blood was 456.8 mV. AuNS-liposome complex showed almost 1.5 fold increase in the photoacoustic signals compared to that of blood. Excitingly, this signal difference was not significantly influenced when they were placed within 1-cm deep inside chicken breast tissue. As shown in Fig. 2d , AuNS-liposome complex shows a peak-to-peak photoacoustic signal of 108.6 mV when being placed under 1-cm fresh chicken breast tissue while blood produces 66 mV. In this case, peak-to-peak photoacoustic signal intensity of AuNS-liposome complex is still~1.5 of that of blood.
Thus the photoacoustic contrast brought by AuNS-liposome complex could be maintained after the filtration of tissue, which suggests that it can be used as a contrast agent for the photoacoustic imaging applications.
Controlled drug release from AuNS-liposome complex
To explore the utilization of AuNS-liposome complex for drug delivery, Dox was encapsulated within the lipid bilayer of the AuNS-liposome complex to form Dox-AuNS-liposome complex. In order to facilitate the encapsulation of Dox in lipid bilayer, TEA was used to deprotonate Dox-HCl to the hydrophobic Dox [13, 20] . For Dox-liposome complex, DI water instead of HAuCl4 was used during the synthesis.
The concentration of Dox within the liposomes was 10% by weight, which was calculated by digesting the Dox-loaded liposomes using Triton X-100 and measuring its absorbance at 480 nm. Formation of AuNSs in the Dox-AuNS-liposome was firstly confirmed through the change in the maximal peak absorbance in the UV-vis spectrum (Fig. 3a) . Different from Dox-liposomes that show the highest absorbance at 480 nm, the maximal absorbance of Dox-AuNS-liposomes shows up at 650 nm. Clearly this NIR absorption was due to the appearance of AuNSs. The formation of AuNSs was further confirmed by lysing the liposomes and examining the extracted AuNSs through TEM (Fig. S3a) . DLS study also revealed that the presence of AuNSs did not significantly change the size of the liposomes (129.3±1.6 nm vs. 115.9±2.5 nm, Fig.  S3b ). We further examined the photoacoustic spectra of Dox-AuNS-liposomes that presented their strongest signal between 660 nm and 750 nm (Fig. S3c) .
Later, Dox-AuNS-liposome solution was exposed to the NIR pulsed laser for varying time points (0-10 seconds) with an energy density of 1.4 mJ cm −2 . As shown in Fig. 3b , the presence of AuNS enables 100% release of encapsulated Dox from the liposomes within only 10 seconds under the laser exposure while the Dox-liposomes have only~10% release under the same experimental condition.
Cell cytotoxicity assay with Dox-AuNS-liposomes
To examine the potential therapeutic effectiveness of Dox-AuNS-liposome complex, the melanoma cells were incubated with AuNS-liposomes, Dox-liposomes, or Dox-AuNS-liposomes with or without the treatment of pulsed laser. Later the cell viability was quantified using Alamar Blue assay and was normalized against the viability of the untreated cells. Dox was maintained at~30 µg mL −1 for the Dox-containing groups and Au concentration was kept at 70 µmol L −1 for AuNSs containing samples. As shown in Fig. 4a , there is negligible cell death for all samples without the treatment of pulsed laser, except the Dox treated groups. However, if the pulsed laser was applied, AuNS-liposome complex and Dox-AuNS-liposome complex resulted in approximately 82.42±5.23% and 93.75±5.37% of cell death. Besides Alamar blue assay, live/dead assay was also performed with CAM and PI (Fig.  4b) , in which the results echoed the Alamar Blue viability assay.
DISCUSSION
HEPES is a moderate reducing agent for the synthesis of gold nanoparticles with different morphologies [9, 10] . The piperazine ring in the HEPES is responsible for the reduc- tion of HAuCl4 from Au 3+ to Au 0 . In this study, we explored the use of HEPES to reduce HAuCl4 that was pre-encapsulated within liposomes. The key is whether HEPES could diffuse through the lipid bilayer of liposomes and whether the HAuCl4 concentration encapsulated in liposomes was sufficient for the formation of AuNSs. The concentrations of HAuCl4 (20 mmol L −1 ) and HEPES (1 mol L −1 ) during the synthesis were selected based on the early work by Xie and Maiorano et al. [9, 21] . Although the diffusion process could not be directly observed, the successful formation of AuNSs on the lipid membrane of liposomes suggested both conditions were met (Figs 1b and c) . The shape of gold nanoparticles could be controlled through tuning the ratio between HAuCl4 and HEPES. However, considering their maximal absorption in the NIR range, AuNSs were made.
Surface-plasmon resonance active nanoparticles such as Au nanoparticles are able to generate photoacoustic signals when being irradiated with a pulsed laser and thus can provide contrast in photoacoustic imaging [22] [23] [24] [25] . The incident pulsed laser is absorbed by Au nanoparticles and converted to heat. Then the thermal energy causes a thermoelastic expansion resulting in pressure wave. The pressure wave is recorded as photoacoustic signal by an ultrasound transducer. We first examined the photoacoustic spectrum of AuNS-liposomes (Fig. 2a) . From 660 to 900 nm, the complex shows the strongest photoacoustic contrast between 750 and 870 nm. Fig. 1a shows that AuNS-liposomes have a maximal absorbance at 803 nm in UV-vis spectrum. Therefore, pulsed diode laser at 803 nm was chosen as the laser source for further experiments.
As expected, the photoacoustic signal intensity has a linear relation with the Au concentration (Fig. 2b) . Moreover, the peak-to-peak photoacoustic signal amplitude was higher than that of blood even under 1-cm deep chicken breast tissue. This confirms that for in vivo photoacoustic imaging applications AuNS-liposome complex can be used as a potential photoacoustic contrast agent.
Recently, we demonstrated that pulsed laser could disrupt liposomes containing Au nanoparticles through microbubble cavitation, which resulted in the release of encapsulated drugs [7] . We believe that a similar phenomenon would be observed with the AuNS-liposome complex. As a proof-of-concept, Dox was incorporated within the lipid bilayer of the liposomes. Although the formation of AuNSs in the Dox-AuNS-liposome complex is evident from the UV-vis absorption spectra (Fig. 3a) and the TEM examination (Fig. S3a) , there is a blue-shift of the absorption spectrum of the Dox-AuNS-liposomes (Fig. S3d) , when compared to that of AuNS-liposomes. This could be attributed to the morphological change of the AuNSs and further studies are required to understand this phenomenon with more details. In addition, the characteristic peak of Dox at 480 nm is not observed in the Dox-AuNS-liposomes (Fig. 3a) . This effect may be due to the negligible or very weak absorption of the Dox or dominant effect of the peak of the AuNSs present in the complex [26] .
The synthesized Dox-AuNS-liposomes were then irradiated with the pulsed laser at 803 nm where Dox-AuNS-liposomes show good absorption (Fig. 3b) . Complete release of Dox from Dox-AuNS-liposome complex was achieved within 10 s. However, there were only~10% Dox released from the Dox-liposomes under the same condition. This clearly indicates that the Dox release from Dox-AuNS-liposome complex was due to the laser stimulation that might execute through heat or microbubble formation.
Finally, the therapeutic effect of Dox-AuNS-liposome complex was explored with melanoma cells (Fig. 4) . Compared with AuNS-liposomes, Dox-liposomes, and Dox-AuNS-liposomes, Dox shows consistent cytotoxicity under both conditions. In contrast, Dox-liposomes did not have much effect on the cell viability. This is because the liposomes have a phase transition temperature at 40.8°C [7] and it has been reported that the cytotoxicity of the drug encapsulated in temperature-sensitive liposomes is highly reduced when maintained at 37°C [27, 28] . AuNS-liposomes are non-toxic without laser treatment. However, the exposure to NIR laser dramatically changes their cytotoxicity, which should be due to the cavitation induced by the microbubble formation due to the transient heating of AuNS-liposomes [29] [30] [31] . As a combination of Dox-liposomes and AuNS-liposomes, Dox-AuNS-liposome complex shows similar non-toxic effects without laser treatment. However, with the treatment of laser, it also shows the highest cytotoxicity due to the synergetic effect of local heating, microbubble cavitation and Dox.
CONCLUSION
In summary, this report introduces the synthesis of AuNSs containing liposomes by the in situ reduction of the gold precursor HAuCl4 through HEPES diffusion and reduction. It allows the formation and simultaneous encapsulation of AuNSs within liposomes. Due to the presence of AuNSs, these liposomes can produce strong photoacoustic signals in the NIR region even at 1 cm deep inside biological tissue. Furthermore, when there are drugs (i.e., Dox) within these liposomes, the irradiation with the NIR pulse laser can disrupt the liposomes and trigger the release of these pre-encapsulated drugs to perform the local treatment. We believe this platform has the potential as a dual-modal theranostic agent since it can be used for both imaging as well as therapy with controlled drug delivery and targeting. In the future studies, we will test the capability further with an in vivo small animal model.
